In severe osteoarthritis, the limiting problem is often structural joint degeneration
That framing creates confusion, unrealistic expectations, and disappointing outcomes
There is no quality assurance, no validated dosing guidance, and no regulatory safety net
Alzheimers & Parkinsons: Early Excitement and Caution Neurodegenerative diseases, particularly Alzheimers and Parkinsons, generated significant patient and research interest
Depending on your goals, your program may include GLP-1 weight loss medications such as semaglutide or tirzepatide, prescription-based weight management, hormone replacement therapy (HRT), testosterone replacement therapy (TRT), advanced diagnostic testing, and structured nutrition support